Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Boadie W. Dunlop, MD: Disturbed Glucose Metabolism Among Patients Taking Olanzapine and Typical Antipsychotics
1
x
$
30.00
Assessment of Anxiety in Clinical Trials with Depressed Patients
1
x
$
30.00
Ellen B. Dennehy, PhD: Concordance with Treatment Guidelines for Bipolar Disorder: Data from the Systematic Treatment Enhancement Program for Bipolar Disorder
1
x
$
30.00
Impact of a Student Pharmacist Driven Medication Reconciliation and Antidepressant Treatment History Project at a Depression Clinic: A Pilot Study
1
x
$
30.00
Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
1
x
$
30.00
Judith J. Wurtman, PhD: The Effect of a Novel Dietary Intervention on Weight Loss in Psychotropic Drug-Induced Obesity
1
x
$
30.00
Impact of Polymorphism of CYP2D6 on Equilibrium Concentration of Duloxetine in Patients Suffering from Major Depressive Disorder
1
x
$
30.00
Psychopharmacology Bulletin VOL 36 Supplement No. 3 - Full Issue Stacked PDF
1
x
$
60.00
View Cart
Checkout
Home
ms
“Psychopharmacology Bulletin VOL 36 Supplement No. 3 – Full Issue Stacked PDF” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Sale!
VOL 3 No. 1 Full Issue – January 2001
$
30.00
Original price was: $30.00.
$
20.00
Current price is: $20.00.
Add to cart
Details
Psychopharmacology Bulletin VOL 36 Supplement No. 3 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Psychopharmacology Bulletin VOL 37 Supplement No. 1 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder
$
30.00
Add to cart
Details
Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication
$
30.00
Add to cart
Details
Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial
$
30.00
Add to cart
Details
Craig H. Mallinckrodt, PhD: Simple Options for Improving Signal Detection in Antidepressant Clinical Trials
$
30.00
Add to cart
Details
Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
$
30.00
Add to cart
Details
Eileen P. Ahearn, MD, PhD: Fear, Anxiety, and the Neuroimaging of PTSD
$
30.00
Add to cart
Details
Strategies for Treatment-Resistant Depression
$
30.00
Add to cart
Details
Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial
$
30.00
Add to cart
Details
Page load link
Go to Top
